Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2006) 11 P230

ECE2006 Poster Presentations Cytokines and growth factors (33 abstracts)

Lack of influence of an IGF-I gene polymorphism on circulating IGF-I levels in severely GHD adults

JAMJL Janssen 2 , A Mukherjee 1 , HK Gleeson 1 , S Lamberts 2 & SM Shalet 1


1Christie Hospital, Manchester, United Kingdom; 2Erasmus MC, Rotterdam, Netherlands.


Considerable overlap in IGF-I levels exists between normal and severely GHD subjects; the mechanisms underlying this observation remain poorly understood. Under various clinical circumstances therefore, IGF-I estimation is an unreliable marker of GH status. A polymorphism in the IGF-I gene influences IGF-I levels in normal populations; a higher IGF-I is associated with the presence of 2 wild type alleles of the IGF-I gene (WTG). The possibility that an IGF-I gene polymorphism could contribute to overlap of unstimulated IGF-I levels between normal and severely GHD adults is investigated.

The study was approved by the local research ethics committee. IGF-I genotype was determined in 128 (72 female, age range 18–82 years) severely GHD adults. Using multiple regression analysis, contributions of IGF-I genotype and the following variables capable of affecting age-adjusted IGF-I in severe GHD were evaluated; gender, timing of onset of GHD, presence or absence of prolactin deficiency, BMI, number of additional pituitary deficits and underlying pathology.

Ninety-eight (76.6%) and 30 (23.4%) subjects possessed WTG and variant IGF-I genotype (VG) respectively. Eighty-seven (68%) had adult-onset GHD. Median IGF-I level was 114.0 μg/l and 121.5 μg/l in WTG and VG respectively (P=0.45). There was no significant difference in weight and height between subjects with WTG and VG. Mean BMI was 29.4±7.22 and 25.7±5.75 for WTG and VG groups respectively (P=0.01). No independent contribution of IGF-I genotype (P=0.78), gender (P=0.38) BMI (P=0.48) and number of additional pituitary deficits (P=0.9) to IGF-I status were detected.

The higher IGF-I level associated with the presence of IGF-I WTG appears lost in severe GHD, consistent with the disturbed GH/IGF-I secretory physiology associated with this condition. Although the confidence intervals are wide for this observation, the presence of factors other than IGF-I genotype, appear to have a greater influence on IGF-I status in severely GHD adults.

Volume 11

8th European Congress of Endocrinology incorporating the British Endocrine Societies

European Society of Endocrinology 
British Endocrine Societies 

Browse other volumes

Article tools

My recent searches

No recent searches.